IMMUNE GLOBULIN NOS for Multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where IMMUNE GLOBULIN NOS was used for Multiple sclerosis.
Most Reported Side Effects for IMMUNE GLOBULIN NOS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 963 | 42.8% | 228 | 533 |
| Off label use | 675 | 30.0% | 113 | 334 |
| Drug ineffective for unapproved indication | 266 | 11.8% | 69 | 143 |
| Condition aggravated | 207 | 9.2% | 31 | 138 |
| Product use in unapproved indication | 143 | 6.4% | 31 | 52 |
| Therapy non-responder | 130 | 5.8% | 14 | 82 |
| Treatment failure | 121 | 5.4% | 12 | 36 |
| Septic shock | 95 | 4.2% | 31 | 86 |
| Diarrhoea | 92 | 4.1% | 9 | 74 |
| Maternal exposure during pregnancy | 83 | 3.7% | 1 | 40 |
| Vomiting | 83 | 3.7% | 6 | 67 |
| Nausea | 81 | 3.6% | 4 | 54 |
| Drug intolerance | 77 | 3.4% | 1 | 67 |
| Disease progression | 67 | 3.0% | 14 | 22 |
| Intentional product use issue | 67 | 3.0% | 14 | 37 |
Other Indications for IMMUNE GLOBULIN NOS
Product used for unknown indication (292)
Immune thrombocytopenia (100)
Haemophagocytic lymphohistiocytosis (98)
Immunosuppressant drug therapy (98)
Dermatomyositis (92)
Covid-19 (83)
Myasthenia gravis (63)
Encephalitis autoimmune (52)
Interstitial lung disease (48)
Juvenile idiopathic arthritis (47)
Other Drugs Used for Multiple sclerosis
DIMETHYL (78,567)
NATALIZUMAB (56,733)
INTERFERON BETA-1A (56,475)
FINGOLIMOD (43,123)
TERIFLUNOMIDE (29,963)
DALFAMPRIDINE (28,787)
GLATIRAMER (27,144)
OCRELIZUMAB (15,501)
OFATUMUMAB (11,816)
PEGINTERFERON BETA-1A (11,105)